Eisai
Global pharmaceutical company focused primarily on neurology and oncology, including Alzheimer's disease therapy Leqembi and oncology medicine Lenvima.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 2 · Recruiting · Narcolepsy
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean ParticipantsNA · Recruiting · Arthritis, Rheumatoid
Study to Evaluate the Pharmacokinetics (PK) of E7090 (Herein Referred to as Tasurgratinib) and Its Metabolite in Participants With Mild and Moderate Hepatic Impairment Compared to Healthy ParticipantsPhase 1 · Recruiting · Hepatic Impairment
A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With LecanemabNA · Recruiting · Alzheimer's Disease
A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic SeizuresNA · Recruiting · Partial-Onset Seizures
A Study of E6742 in Participants With Systemic Lupus ErythematosusPhase 2 · Recruiting · Systemic Lupus Erythematosus
Selected patent records
lenvatinib mesylate · Expires 2025-10-24
US 7253286*PEDlenvatinib mesylate · Expires 2026-04-24
US 7612208lenvatinib mesylate · Expires 2026-09-19
US 7612208*PEDlenvatinib mesylate · Expires 2027-03-19
US 9006256lenvatinib mesylate · Expires 2027-07-27
US 9006256*PEDlenvatinib mesylate · Expires 2028-01-27
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/eisai/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.